Woodline Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-139,095
Closed -$28.2M – 1118
2025
Q3
$28.2M Buy
139,095
+15,425
+12% +$2.74M 0.13% 212
2025
Q2
$21.8M Buy
+123,670
New +$18.6M 0.12% 262
2024
Q4
– Sell
-74,233
Closed -$12.3M – 998
2024
Q3
$12.3M Sell
74,233
-53,468
-42% -$8.09M 0.1% 263
2024
Q2
$17M Buy
+127,701
New +$15.4M 0.16% 186
2023
Q4
– Sell
-71,830
Closed -$4.73M – 653
2023
Q3
$4.73M Buy
+71,830
New +$5.37M 0.06% 316
2022
Q2
– Sell
-92,970
Closed -$7.99M – 888
2022
Q1
$7.99M Buy
92,970
+25,975
+39% +$2.13M 0.13% 193
2021
Q4
$5.47M Sell
66,995
-41,633
-38% -$3.04M 0.08% 272
2021
Q3
$7.22M Sell
108,628
-57,362
-35% -$4.07M 0.12% 209
2021
Q2
$11.1M Buy
+165,990
New +$10.3M 0.21% 126
2021
Q1
– Sell
-77,826
Closed -$3.11M – 474
2020
Q4
$3.11M Buy
+77,826
New +$2.51M 0.08% 180

Other funds holding THC

Woodline Partners's THC Position: Q4 2025 in Review

Woodline Partners sold out of Tenet Healthcare (THC) in Q4 2025, closing a stake of 139,095 shares — an estimated $28.2M sold.

Woodline Partners first reported a position in THC in Q4 2020 and held it in 10 quarters. The position peaked at $28.2M in Q3 2025. 705 funds tracked by Wall St. Rank hold THC as of Q4 2025.

  • Woodline Partners reported no remaining Tenet Healthcare position as of Q4 2025 after selling out during the quarter.
  • Woodline Partners sold 139,095 Tenet Healthcare shares in Q4 2025, an estimated $28.2M.
  • Woodline Partners first reported a position in Tenet Healthcare in Q4 2020 and held it in 10 quarters.
  • Woodline Partners's Tenet Healthcare position peaked at $28.2M in Q3 2025.
  • 705 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.